Most recent study confirms GLP-1 drugs show no elevated cancer risk.

This systematic review and meta-analysis examined whether GLP-1 receptor agonists and dual agonists are linked to an increased risk of cancer. The authors found no significant association with overall cancer incidence, providing reassuring safety data for patients and clinicians using these metabolic therapies. Read the full study →

Is Your Brain Tired? Scientists Explore the Roots of Mental Fatigue

New research shows that mental fatigue is tied to real, measurable changes in brain activity and metabolism — offering clues that could improve diagnosis and treatment for long COVID and other disorders marked by persistent cognitive exhaustion. Read the full article →